ASND

Q: What is the price of Ascendis Pharma (ASND) today?

The price of Ascendis Pharma (ASND) today is $ 199.99, with return of 45.19% compared to the last year. The price of Ascendis Pharma (ASND) started the year trading around $ 137.67 and today it is at $ 199.99. Follow the real-time price chart, the historical price of Ascendis Pharma (ASND) and international markets.

Q: When does Ascendis Pharma (ASND) pay dividends?

Ascendis Pharma (ASND) did not distribute dividends in the last year.

Q: Is Ascendis Pharma (ASND) worth it?

Currently, Ascendis Pharma (ASND) is priced at $ 199.99, with a P/E of -51.92%, representing a deviation of -1,474% from its historical average P/E. In the last year, the stock showed a variation of 45.19 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 45.19%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Ascendis Pharma (ASND) stock?

Investing in stocks of Ascendis Pharma (ASND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Ascendis Pharma (ASND) yield today?

The yield of Ascendis Pharma (ASND) was -5.73% in the last month, 45.19% in the last year and 12.99% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Ascendis Pharma (ASND) today, the total investment would be $ 19,999.00, based on the current price of $ 199.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 29,036.55In 5 years: $ 22,596.87In 10 years: $ 224,318.78It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Ascendis Pharma A/S

Price

$ 199.99

return (12m)

45.19%

p/e

-51.92

p/bv

-65.81

DIVIDEND YIELD

0.00%

price ASND

ASND

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of ASND

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.73%

3 months

1.17%

1 year

45.19%

2 years

65.06%

5 years

12.99%

10 years

1,021.65%

Fundamentals ASND

review the fundamentals of Ascendis Pharma shares

P/E

-51.92

Sector: -3.65 Industry: -3.65

P/SALES RATIO (PSR)

18.56

Sector: -3.79 Industry: -3.79

P/BV

-65.81

Sector: 2.05 Industry: 2.05

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-19.11%

Sector: -63.54% Industry: -63.54%

ROE

126.75%

Sector: -66.83% Industry: -66.83%

ROIC

4.39%

Sector: -1,129.15% Industry: -1,129.15%

NET MARGIN

-35.76%

Sector: -41.11% Industry: -41.11%

GROSS MARGIN

86.73%

Sector: 39.39% Industry: 39.39%

OPERATING MARGIN

-22.15%

Sector: -40.98% Industry: -40.98%

P/EBITDA

-104.07

Sector: -3.65 Industry: -3.65

P/EBIT

-93.65

Sector: -3.78 Industry: -3.78

P/ASSET

9.92

Sector: 1.49 Industry: 1.49

BVPS

-3.35

Sector: 1.75 Industry: 1.75

EPS

-4.25

Sector: -2.04 Industry: -2.04

EQUITY RATIO

-0.15

Sector: 0.41 Industry: 0.41

CAGR REVENUE 5 YEARS

-86.86%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-95.28%

Sector: - Industry: -

Fundamentals ASND

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.28	0.00	0.00%	2.43%	$ 509.48 B	27.26%
PFE	14.95	1.58	10.56%	6.65%	$ 146.96 B	15.65%
ABBV	168.68	-154.98	-91.88%	2.88%	$ 402.80 B	4.00%
NVO	14.47	8.35	57.70%	3.36%	$ 223.00 B	32.78%
MRK	13.16	0.00	0.00%	3.23%	$ 250.55 B	29.63%
AZN	29.65	6.06	20.45%	1.74%	$ 278.65 B	16.17%
BMY	17.67	5.74	32.47%	4.73%	$ 106.71 B	12.57%
GILD	18.45	6.98	37.80%	2.61%	$ 149.66 B	27.88%
ZTS	19.83	9.74	49.11%	1.69%	$ 52.57 B	28.21%
HALO	12.22	14.44	118.17%	0.00%	$ 7.28 B	47.91%
REGN	16.84	2.49	14.79%	0.47%	$ 77.09 B	32.13%
AMGN	24.40	17.77	72.82%	3.00%	$ 170.94 B	19.47%
VRTX	31.49	6.68	21.22%	0.00%	$ 115.72 B	31.35%
MCK	25.02	-174.59	-697.75%	0.36%	$ 100.91 B	1.04%
CAH	29.57	-17.27	-58.40%	1.03%	$ 47.17 B	0.68%
ADMA	22.57	10.96	48.57%	0.00%	$ 4.73 B	42.87%
BIIB	15.91	1.41	8.83%	0.00%	$ 25.59 B	15.98%
HRMY	12.65	2.81	22.24%	0.00%	$ 2.35 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ASND Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Ascendis Pharma

Ascendis Pharma A/S

Average user rating I10

4.0 (2 people)

United States

19 years

Founded: 2006

2015

Time since IPO - 10 years

482

Employees

The Company Ascendis Pharma A/S (United States), is listed on Nasdaq with a market value of $ 13.45 Billions, having an equity of $ -204.31 Millions.

With a total of 482 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 724.28 Millions, which generated a loss in the amount of $ -258.97 Millions.

As for its main indicators, the Company has a P/E ratio of -51.92, a P/BV ratio of -65.81 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ASND.

Market cap

$ 13.45 Billions

Net worth

$ -204.31 Millions

US$ -204,310,000.00

Assets

$ 1.36 Billion

US$ 1,355,340,000.00

Total Shares Outstanding

61.00 Millions

61,000,000

Average Daily Trading Volume

$ 581.79 Thousand

US$ 581,787.08

Sector

Health Care

Industry

Biotechnology

ASND

ASND revenue and profits

Financial Results ASND

DRAG THE FRAME TO SEE MORE DATA

ASND cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 820.25 42,25% (12M)

P/E

25.02

0.36%

ROE

-697.75%

P/BV

-174.59

CAH - Cardinal Health

$ 202.95 74,50% (12M)

P/E

29.57

1.03%

ROE

-58.40%

P/BV

-17.27

JNJ - Johnson & Johnson

$ 206.37 47,22% (12M)

P/E

20.28

2.43%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 101.09 7,83% (12M)

P/E

13.16

3.23%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.19 1,13% (12M)

P/E

14.95

6.65%

ROE

10.56%

P/BV

1.58

ABBV - AbbVie

$ 226.82 34,72% (12M)

P/E

168.68

2.88%

ROE

-91.88%

P/BV

-154.98

AZN - AstraZeneca

$ 91.36 42,78% (12M)

P/E

29.65

1.74%

ROE

20.45%

P/BV

6.06

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 820.25 42,25% (12 M)

P/L

25.02

0.36%

ROE

-697.75%

P/VP

-174.59

CAH - Cardinal Health

$ 202.95 74,50% (12 M)

P/L

29.57

1.03%

ROE

-58.40%

P/VP

-17.27

JNJ - Johnson & Johnson

$ 206.37 47,22% (12 M)

P/L

20.28

2.43%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 101.09 7,83% (12 M)

P/L

13.16

3.23%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.19 1,13% (12 M)

P/L

14.95

6.65%

ROE

10.56%

P/VP

1.58

ABBV - AbbVie

$ 226.82 34,72% (12 M)

P/L

168.68

2.88%

ROE

-91.88%

P/VP

-154.98

AZN - AstraZeneca

$ 91.36 42,78% (12 M)

P/L

29.65

1.74%

ROE

20.45%

P/VP

6.06

Frequently Asked Questions

What is the price of Ascendis Pharma (ASND) today?

The price of Ascendis Pharma (ASND) today is $ 199.99, with return of 45.19% compared to the last year. The price of Ascendis Pharma (ASND) started the year trading around $ 137.67 and today it is at $ 199.99. Follow the real-time price chart, the historical price of Ascendis Pharma (ASND) and international markets.

When does Ascendis Pharma (ASND) pay dividends?

Ascendis Pharma (ASND) did not distribute dividends in the last year.

Is Ascendis Pharma (ASND) worth it?

Currently, Ascendis Pharma (ASND) is priced at $ 199.99, with a P/E of -51.92%, representing a deviation of -1,474% from its historical average P/E. In the last year, the stock showed a variation of 45.19 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 45.19%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Ascendis Pharma (ASND) stock?

Investing in stocks of Ascendis Pharma (ASND) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Ascendis Pharma (ASND) yield today?

The yield of Ascendis Pharma (ASND) was -5.73% in the last month, 45.19% in the last year and 12.99% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Ascendis Pharma (ASND) today, the total investment would be $ 19,999.00, based on the current price of $ 199.99.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 29,036.55
In 5 years: $ 22,596.87
In 10 years: $ 224,318.78

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ASND

Ascendis Pharma A/S

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of ASND

review the fundamentals of Ascendis Pharma shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Ascendis Pharma

Ascendis Pharma A/S

United States

19 years

2015

482

PROFIT X PRICE ASND

Financial Results ASND

ASND cash flow

asset growth - ASND

ASND balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions